Pancreatic Parenchymal Injection of N-Butyl-2-Cyanoacrylate for Pancreaticojejunostomy After Pancreaticoduodenectomy: A Novel Technique

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07132541

Title field or adapter rule

{'original_value': 'Pancreatic Parenchymal Injection of N-Butyl-2-Cyanoacrylate for Pancreaticojejunostomy After Pancreaticoduodenectomy: A Novel Technique', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:26.019719+00:00

Published At

2026-09-11T00:00:00+00:00

Record Updated At

2026-09-11

Source Retrieved At

2026-10-31T22:17:56.788771+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pancreaticoduodenectomy", "Postoperative Pancreatic Fistula", "Pancreas Cancer", "Periampullary Cancer"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-09-11", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07132541"

protocolSection.identificationModule.officialTitle

"Pancreatic Parenchymal Injection of N-Butyl-2-Cyanoacrylate for Pancreaticojejunostomy After Pancreaticoduodenectomy: A Novel Technique"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Pancreaticoduodenectomy (protocolSection.conditionsModule.conditions)
• Postoperative Pancreatic Fistula (protocolSection.conditionsModule.conditions)
• Pancreas Cancer (protocolSection.conditionsModule.conditions)
• Periampullary Cancer (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['N-butyl-2-cyanoacrylate (Histoacryl® )Injection Group.'], 'description': "This procedure is integrated into the standard pancreaticoduodenectomy.\n\nInjection of Histoacryl® (n-butyl-2-cyanoacrylate) mixed with Lipiodol® (1:1 ratio) into the pancreatic parenchyma circumferentially (3, 6, 9, and 12 o'clock positions) around the main pancreatic duct (MPD) orifice, extending 5-8 mm deep and 5-10 mm laterally from the future anastomotic line, avoiding the main pancreatic duct and vessels. Total volume injected typically ranges from 0.2 ml to 0.6 ml.\n\nFollow with standard duct-to-mucosa pancreaticojejunostomy:\n\n* Tying down the posterior duct-to-mucosa sutures.\n* Placing and tying the anterior duct-to-mucosa sutures.\n* Tying down the posterior outer layer sutures.\n* Placing the anterior outer layer sutures. Meticulously avoid glue contact with sutures/mucosa\n\nReconstruction: Complete the hepaticojejunostomy and duodenojejunostomy (or gastrojejunostomy).", 'name': 'Pancreatic parenchymal injection of N-butyl-2-cyanoacrylate(Histoacryl®)', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Pancreatic parenchymal injection of N-butyl-2-cyanoacrylate(Histoacryl®) (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.